Table 3.
Outcome measures for EARLY and LATE groups.
| EARLY group |
LATE group |
|||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted mean | Adjusted mean | Mean change from baseline | Unadjusted mean | Adjusted mean | Mean change from baseline | Mean diff between groups | p value | |
| AOFAS | ||||||||
| Baseline (SD/CI) | 41.58 ± 12.85 | 53.19 (49.47 to 56.92) | 42.14 ± 9.22 | 57.13 (52.86 to 61.41) | ||||
| 3 Month (SD/CI) | 63.74 ± 13.38 | 64.42 (60.19 to 68.65) | 11.23 (6.83 to 15.62) | 62.76 ± 9.59 | 61.25 (56.88 to 65.62) | 4.12 (−0.55 to 8.78) | 3.17 (−2.91 to 9.25) | .31 |
| 6 Month (SD/CI) | 84.46 ± 9.07 | 85.58 (80.83 to 90.32) | 32.95 (27.49 to 37.27) | 81.1 ± 12.48 | 82.49 (78.06 to 86.93) | 25.36 (20.6 to 30.12) | 3.08 (−3.41 to 9.58) | .35 |
| LEFS | ||||||||
| Baseline (SD/CI) | 20.08 ± 10.73 | 22.39 (17.77 to 27) | 17.17 ± 11.68 | 25.13 (20.13 to 30.12) | ||||
| 3 Month (SD/CI) | 34.22 ± 13.59 | 34.74 (30 to 39.5) | 12.36 (8.49 to 16.23) | 29 ± 14.1 | 28.6 (23.65 to 33.56) | 3.48 (0.63 to 7.58) | 6.14 (−0.72 to 13) | .08 |
| 6 Month (SD/CI) | 64.54 ± 8.76 | 67.24 (61.84 to 72.65) | 44.86 (40.19 to 49.52) | 60.05 ± 12.11 | 59.95 (54.85 to 65.05) | 34.82 (30.53 to 39.12) | 7.29 (−0.14 to 14.72) | .05 |
| ROM | ||||||||
| Baseline (SD/CI) | 30.62 ± 7.68 | 23.77 (21.12 to 26.42) | 29.3 ± 9.3 | 29.3 ± 9.3 | ||||
| 3 Month (SD/CI) | 13.25 ± 4.49 | 13.07 (10.34 to 15.8) | 10.7 (7.93 to 13.47) | 12.8 ± 7.28 | 12.8 ± 7.28 | 5.32 (2.18 to 8.46) | 0.3 (−3.76 to 4.36) | .88 |
| 6 Month (SD/CI) | 8.46 ± 5.77 | 7.22 (3.88 to 10.56) | 16.55 (13.17 to 19.93) | 7.22 ± 6.01 | 7.22 ± 6.01 | 11.26 (8.02 to 14.49) | 0.39 (2.87 to 6.54) | .44 |
Abbreviations: Diff, Difference; Betw, Between; AOFAS, American Orthopeadic Foot and Ankle Society Hindfoot Scale; LEFS, Lower Extremity Functional Scale; ROM, range of motion.